LEXINGTON, Mass., May 5, 2026 /PRNewswire/ -- Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of emavusertib (CA-4948), an orally available, small molecule IRAK4 and FLT3 inhibitor, today announced that the Company will report its first quarter 2026...
Hence then, the article about curis to report first quarter 2026 financial and operating results and host conference call and webcast on may 12 2026 was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Curis to Report First Quarter 2026 Financial and Operating Results and Host Conference Call and Webcast on May 12, 2026 )
Also on site :
- Has social justice become the new religion of the West?
- Inside the chaos at Canoo, the zero-revenue, cash-burning EV company that just inked a major deal with Walmart
- Why This Hidden SoCal Valley’s Historic Hot Springs Deserve A Detour This Summer